Chris Ocampo
Head of Psychiatry, Neuroscience Clinical Development Abbvie
Seminars
Thursday 10th December 2026
An Overview of AbbVie’s Diverse Neuropsychiatry Pipeline
2:00 pm
- Reviewing AbbVie’s abundant pipeline spanning a range of assets in mood disorders
- Highlighting AbbVie’s priorities and commitment to advancing treatments in MDD, BPD and Schizophrenia
- General overview of programs in Neurology, Neurodegeneration, Migraine and Pain
